People: Geron Corp (GERN.OQ)

GERN.OQ on NASDAQ Stock Exchange Global Select Market

3.00USD
11 Jul 2014
Price Change (% chg)

$0.09 (+3.09%)
Prev Close
$2.91
Open
$2.91
Day's High
$3.04
Day's Low
$2.90
Volume
597,016
Avg. Vol
937,175
52-wk High
$7.77
52-wk Low
$1.27

Search Stocks

Rosenfield, Stephen 

Brief Biography

Mr. Stephen N. Rosenfield, J.D., is Executive Vice President, General Counsel and Corporate Secretary of Geron Corporation. He served as the General Counsel and Secretary since January 2012 and Secretary since October 2011. From July 2009 to February 2012, Mr. Rosenfield has been a consultant to private companies. From October 2008 until June 2009, Mr. Rosenfield was the General Counsel and Secretary of Tercica, Inc., a U.S. subsidiary of Ipsen, SA., a global specialty pharmaceutical company. From June 2004 until October 2008, Mr. Rosenfield was the General Counsel and Secretary of Tercica, Inc., an endocrinology-oriented biopharmaceutical company, from January 2006 until October 2008, he was also the Executive Vice President of Legal Affairs, and from June 2004 until January 2006, Mr. Rosenfield was the Senior Vice President of Legal Affairs. Prior to joining Tercica, Mr. Rosenfield served as the Executive Vice President of Legal Affairs, General Counsel and Secretary of InterMune, Inc., a biotechnology company focused in pulmonology and fibrotic diseases. Prior to joining InterMune, Mr. Rosenfield was an attorney at Cooley LLP, an international law firm, where he served as outside counsel for biotechnology and technology clients. Mr. Rosenfield received a B.S. from Hofstra University and a J.D. from Northeastern University School of Law.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
255,500 -- 931,781 1,187,280

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Hoyoung Huh

--

John Scarlett

1,344,950

Olivia Bloom

578,818

Stephen Rosenfield

1,187,280

Andrew Grethlein

801,606

Melissa Kelly Behrs

830,707
As Of 30 Dec 2012
Search Stocks